The terminal differentiation of postmitotic oligodendrocytes is marked by the induction of myelin-specific genes. The formation of myelin is dependent upon the developmentally regulated expression of a set of glial-specific genes. These genes encode the proteolipid protein (PLP), myelin basic protein (MBP), 2',3' cyclic nucleotide-phoshodiesterase (CNP), myelinassociated glycoprotein (MAG), protein zero (P,), and other proteins unique to myelin. Important insights about the structure and function of these proteins have been gained from the cloning of their cDNAs, from their functional expression in heterologous cells, and from the molecular analysis of mutations in myelin-deficient mice (reviewed in Lemke, 1988) . Very little is known about the mechanisms underlying the induction and regulated expression of these myelin-specific genes in developing oligodendrocytes, however. Antibodies against stage-specific cell surface markers (Schachner et al., 198 1 j have been used to monitor the differentiation of oligodendroglial precursor cells in mixed primary cell cultures. In dissociated cultures of rat optic nerve, bipotential pre-exit the cell cycle and differentiate into oligodendrocytes. This process marks their default pathway of development (reviewed by Raff, 1989) . Commitment of precursor cells to the oligodendroglial lineage is then followed by activation of the major myelin genes (e.g., those encoding PLP and MBP). Although studies of cultured glial stem cells have provided important insights into the factors that regulate their development, these precursors are difficult to isolate in the large quantities required for biochemical analyses of gene regulation. We have therefore investigated the ability of a clonal glial cell line to "differentiate" in culture and express myelin-specific genes, and have focused on the gene encoding PLP, a 30 kDa integral membrane protein and major structural component of CNS myelin (Lees and Brostoff, 1984; Nave and Milner, 1989) . Ideally, a cell line transcribing the PLP gene should serve both as an in vivo system for the characterization of c&regulatory elements in this gene, and as a source of the corresponding truns-acting factors.
Only a few established cell lines are known to have oligodendroglial properties, and no glial cell line is presently known to express all of the myelin-associated genes that are transcribed in differentiated oligodendrocytes. The rat glioblastoma line C6, one of the first glioma lines adapted to culture (Benda et al., 1968) , expresses a repertoire of enzymatic activities (Volpe et al., 1975; McMorris, 1977; Kumar et al., 1984) that are characteristic of both astrocytes and oligodendrocytes. C6 cells may therefore have derived from the transformation of a common precursor cell of the macroglial cell lineage. In this respect, these cells are related to the bipotential O-2A glial stem cells of the rat optic nerve (Raff et al., 1983) . We show here that C6 cells that differentiate in culture induce high-level expression of the PLP gene. In exponentially growing cells cultured with frequent changes of serum-containing media, PLP mRNAs are virtually absent; following growth arrest at high cell density or in serumfree medium, the PLP gene is induced. Using this system, we characterize the promotor region of the rat PLP gene and find that transcriptional activation of PLP in C6 cells is regulated by elements located within a 1 Kb region upstream of exon I. We identify multiple nuclear protein binding sites in this region: one of these binding sites contains a sequence element that is also found in the 5' regulatory regions of the MBP, MAC, and P, genes. This raises the possibility that common truns-acting factors are involved in the coordinate expression of the major myelin proteins. GIBCO) containing 10% fetal calf serum (FCS; GIBCO), 100 U/ml penicillin, and 100 &ml streptomycin. Where indicated, forskolin (Calbiochem) was added to 20 PM fmal concentration and 12-O-tetradecanoylphorbol 13-acetate (TPA, Sigma) to 100 @ml. Northern blot analysis. Total RNA was isolated using the guanidine thiocyanate/water-saturated phenol procedure ofChomczynski and Sacchi (1987) . Total RNA (5 fig) or polyA+-selected RNA (2 pg) was fractionated on 1 .O% agarose gels in 1 M formaldehyde, transferred to Nytran membranes (Schleicher and Schiill, Keene, NH), and hybridized with 32P-labeled probes in 50% formamide, 0.75 M NaCl, 25 m&i 1,4-p&r-azinediethanesulfonic acid (PIPES) (PH 6.8), 0.2% SDS, 25 mM EDTA, 100 &ml salmon sperm DNA, and 5 x Denhardt's solution at 42°C overnight. Probes were generated by random prime labeling the inserts of cDNA clones of rat PLP (Milner et al., 1985) , mouse MBP (Roach et al., 1983) , rat MAG , rat CNP (Bemier et al., 1987) , rat vimentin, and rat glial fibrillary acidic protein (GFAP) (D. Feinstein, G. Weinmaster, and R. Milner, unpublished observations) . Blots were washed twice in 2 x saline-sodium citrate (SSC)/O.5% SDS and once in 0.4 x SSC/O.2% SDS at 65°C and exposed to Kodak X-AR film at -70°C with Cronex Lightning Plus intensifying screens for 12-24 hr.
Cloning, sequence analysis, plmmid construction. The rat PLP gene was isolated from a genomic library in X-Charon 4A, using the PLP cDNA clone p27 as a probe (Milner et al., 1985) . A 1.3-Kb EcoRI fragment containing the promotor region was subcloned into pUCl8, nested deletions were generated with exoIII/mung bean nuclease (Stratagene), and the nucleotide sequence was determined by the chain termination method using a Sequenase kit (U.S. Biochemical Co.). The 1188-base pair (bp) EcoRI-BamHI promotor fragment was cloned into the polylinker upstream of the chloramphenicol acetyltransferase (CAT) gene in pBLCAT3 (Luckow and Schlitz, 1988) , generating clone CAT-1038. A series of 5' deletions of CAT-1038 was generated with exoIIV mung bean nuclease, and the position of each 5' end was determined by sequence analysis. The numbering of the deletion clones refers to the position of their respective 5' ends relative to the first transcription start site of the rodent PLP gene (Milner et al., 1985; Ikenaka et al., 1988) , except for CAT-77, which is labeled with reference to the most 3' transcription start site at +74. A 1.38-Kb HindIII-BspM2 fragment of the mouse MBP gene (Takahashi et al., 1985) was ligated into the Hind111 and Xmal site of pKS+ (Stratagene), excised with Hind111 and BamHI, and religated into the upstream polylinker of pBLCAT3. Plasmid DNAs were purified on cesium chloride gradients.
Transfections and CAT assays. Calcium phosphate-mediated transfections (10 pg per 60 mm plate) were performed as described by Graham and van der Eb (1973) and Wigler et al. (1979) . Cells were either plated at 4 x lOJ/cm2 1 d before transfection and harvested 2 d later (protocol 1) or plated at 4 x 104/cm2 and harvested 3-4 d after trans- Figure 1 . Expression of glial-specific genes in brain and C6 glioblastoma cells. In each Northern blot, 2.0 pg of polyA+ RNA of 4-week-old mouse brain (BR) is compared to the same amount of polyA+ RNA from rat C6 cells, harvested either at low cell density (LD) or at high cell density (t;lB) (see Fig. 2 ). Blots were hybridized to -'*P-radiolabeled cDNA probes encoding the following proteins: A, PLP; B, CNP; C, MBP; D, MAG; E, vimentin; F, GFAP. The size difference between rat and mouse PLP mRNAs results from alternative use of polyadenylation signals (Nave et al., 1986) . Equal loading of RNA was verified both by methylene blue staining and by reprobing the blots for expression of elongation factor EFl cr-mRNA (not shown). fection (protocol 2). To ensure induction ofthe PLP gene at high density, cultures that had not reached confluence by 72 hr alter transfection were discarded. Transfection efficiency was monitored by cotransfecting a luciferase expression construct (3 pg) driven by either the SV40 early promotor (deWet et al., 1987) or by the promotor of the rat PLP gene. C6 cells stably transfected with CAT-1038 were obtained by cotransfecting 1 .O ,ug pRSVneo (Gorman et al., 1983) and selecting clones in the presence of 400 &ml G418 (GIBCO). Chloramphenicol acetyltransferase (CAT) activity was determined in cell extracts by the method of Gorman et al. (1982) and was normalized to transfection efficiency. After thin-layer chromatography and autoradiography, acetylated and nonacetylated 14C-chloramphenicol was quantitated in a scintillation counter. Mean and standard deviations of chloramphenicol conversion rates were calculated from the results of three separate experiments.
Analysis of DNA binding proteins. Nuclear protein extracts from 1 O9 C6 cells and 3T3 cells grown to high density were prepared as described by Ohlsson and Edlund (1986) and as modified by Christy et al. (1989) . Brain nuclear extracts from 4-week-old Balb/c mice were prepared by the method of Gorski et al. (1986) . All protein extracts were dialyzed twice against a buffer containing 25 mM HEPES (pH 7.6), 40 mM KCI, 0.1 mM EDTA, 1 mM dithiothreitol (DTT), 0.1 mM phenylmethylsulfonyl fluoride (PMSF), and 10% glycerol. End-labeled restriction fragments were generated with DNA polymerase I (Klenow) utilizing the following restriction sites in the rat PLP promotor: EcoRI (-1043), AiuI(-570),NcoI(-435),DraI(-29l),XbaI (-192) ,HindIII(-l84), Hinfl (-112), and BamHI (+86). DNase I protection analysis (20,000 cpm probe) with 2.0 pg poly-dIdC competitor DNA and up to 90 rg of nuclear protein extract was carried out as described by Mangalam et al. (1989) .
Results
Expression of myelin-specific genes by 05 cells We initially analyzed C6 cells for the expression of several myelin-specific genes. As shown in the Northern blots of Figure 1 , mRNAs characteristic of both astrocytes and oligodendrocytes were present. However, the abundance of some mRNAs was strongly influenced by the cell density at the time of harvest (Fig. 2) . In particular, expression of PLP mRNA was markedly increased after C6 cells reached confluence. In high-density cultures, the level of PLP mRNA approached that of adult mouse brain (Fig. 1A) . In contrast, in exponentially growing C6 cells, expression of PLP mRNA was very low and was nearly unde- tectable when the culture medium was changed daily (Fig. 3A, lane b). MBP and MAG mRNAs could not be detected under any culture conditions tested ( Fig. 1 CD) , but transcripts of the gene encoding the enzyme CNP, an early oligodendrocyte marker, were equally abundant at both low and high cell density (Fig.  1B ). In agreement with previous immunohistochemical data (Raju et al., 1980) , we found low levels of GFAP mRNA in C6 cultures, indicating the presence of astrocyte-like cells, but we did not observe a significant change in its abundance in confluent as opposed to rapidly growing cells ( Fig. 10 . The abundance of vimentin mRNA, often used as a marker for glial precursor cells and astrocytes (Schnitzer et al., 1981) was significantly downregulated at high cell density (Fig. 1E ).
Induction of PLP mRNA by cell contact and CAMP As noted above, PLP mRNA was barely detectable in C6 cells cultured at low density in serum-containing medium that was changed daily. Induction of the PLP gene in response to serum removal or high culture density appeared to be an intrinsic property of C6 cells, since a 24 hr incubation with medium conditioned by confluent cells did not induce PLP expression in cells cultured at low density (data not shown). Moreover, when FCS was removed from the medium for 24 hr, significant amounts of PLP mRNA could be detected even in cells cultured at low density (Fig. 3A , lane c), and the abundance of PLP mRNA in cells at high density was further increased by serum removal. The dramatic increase in steady-state PLP mRNA levels observed upon switching C6 cells from low cell density in 10% FCS to high cell density in serum-free medium was reversible (not shown).
To determine whether the inducing effect of cell<ell contact involves a known second-messenger system, we added the protein kinase C activator TPA and the adenylate cyclase activator forskolin to cultures of exponentially growing or confluent C6 cells. As shown in Figure 3B , neither agent induced PLP mRNA over control after 3 hr of treatment, but after 20 hr a significant induction of PLP mRNA was observed in cells cultured at low density and treated with forskolin ( Fig. 3C ). The 20 hr forskolin stimulation did not significantly increase PLP mRNA in cultures that had already reached confluence.
Transcriptional activation of the PLP gene
We isolated genomic clones of the rat PLP gene from a rat genomic library . A 1125 bp EcoRI-BamHI fragment from the 5' end of this gene was sequenced (Fig. 4) and ligated upstream of the bacterial CAT reporter gene in the vector pBLCAT3 (Luckow and Schtitz, 1988) . This fragment contains the presumptive PLP promotor region, including four identified transcription start sites and much of the 5' untranslated region (Milner et al., 1985; Ikenaka et al., 1988; Boison and Stoffel, 1989) .
When this hybrid reporter plasmid (CAT-1038) was transiently transfected into rapidly proliferating C6 cells using a standard calcium phosphate precipitation protocol (Wigler et al., 1979) , CAT expression was very low compared to the signal obtained when the same CAT gene was driven by the SV40 early promotor (Fig. 5) . However, when the transient transfection protocol was modified to allow C6 cells to reach and maintain high density after transfection (protocol 2 in Fig. 5A ), the specific CAT activity of cellular extracts increased by more than an order of magnitude. Unfortunately, it was impossible to compare directly the absolute CAT activities obtained with these two transfection protocols due to the decrease in transfection efficiency observed at high cell density, and the presumed accumulation of CAT protein and loss of template DNA with time. Nonetheless, growth arrest conditions that induced abundant expression of the endogenous PLP gene also strongly potentiated expression of the transfected PLP promoter-CAT gene. These growth arrest conditions did not potentiate expression of a transfected reporter construct in which transcription of the CAT gene was driven by the SV40 early promotor. We obtained results comparable to these in a C6 subline stably transfected with clone CAT-1038. Growth to either low, medium, or high density as defined in Figure 2 , the specific CAT activity in cell extracts (per microgram of soluble protein) was increased over lo-fold in confluent cells (Fig. 5B) , in close agreement with the observed induction of the endogenous PLP gene.
To determine whether transfection protocol 2 might also be used to study the regulation of other myelin-specific genes in C6 cells, we placed the CAT gene under the control of a 1380 bp 5' flanking HindIII-BspM2 fragment from the mouse MBP gene (Takahashi et al., 1985) . Even though expression of the endogenous MBP gene was never detected in C6 cells cultured at either low or high density (Fig. l) , we observed a strong MBP-CAT signal, comparable to that obtained with the PLP clone CAT-1038, in transiently transfected C6 cells (data not shown). No MBP promotor-driven CAT activity was observed in transfected NIH3T3 fibroblasts. The PLP gene contains positive and negative regulatory elements To identify the position of transcriptional control elements, we progressively truncated the 5' regulatory region of the PLP gene in a 5' to 3' direction from position -1038 and placed these promotor deletions upstream of the CAT reporter gene (Fig. 6 ).
In these experiments, transient expression of the deletion clones was first studied in induced C6 cells at high density (transfection protocol 2). Since the expression of CAT-1038 was severely influenced by culture conditions (cell density, serum factors), minor variations between individual cultures might easily mask the effect of sit@e regulatory elements on promotor activity. To control for these variations and for overall transfection efficiencies, we cotransfected for each deletion point a plasmid containing the firefly luciferase gene (deWet et al., 1987) under the control of the 1038 bp rat PLP promotor. All CAT assays were thus normalized to the activity of clone CAT-1038 in this system, and the chloramphenicol conversion rates for deletion clones shown in Figure 6 were normalized to equal luciferase activity. Actual conversion rates were always in the linear range of the CAT assay. This normalization protocol results in a level of PLP promotor competition that can be accurately estimated and that does not prevent detection of transcriptional control elements. A striking result from this analysis was that the transcriptional activity of some deletion clones was significantly higher in the absence rather than the presence of their respective 5' flanking fragments (Fig. 6) . Specifically, sequences immediately upstream of -186, -39 1, and -690 had a negative effect on the transcriptional activity of the CAT construct, while positive cisregulatory elements were located between -39 1 and -297, and between -690 and -480. A 1 O-fold drop in promotor activity observed upon deletion of sequences immediately upstream of the core promotor was likely the consequence of an inactivated CCAAT box in clone CAT-146 (see below). All results are the mean of at least three separate experiments, and SDS have been indicated in parentheses. These data strongly suggest that the activity of the induced PLP promotor is controlled by both positive and negative &regulatory elements.
We next introduced the same set of deletion clones into C6 cells maintained at low density (following protocol 1) to test the possibility that negative regulatory elements might be involved in the repression of PLP transcription at low cell density. Because the level of PLP promoter-driven transcripts were anticipated to be quite low in these transfections, we normalized CAT activity to luciferase activity by cotransfecting a plasmid in which transcription of the luciferase gene was driven constitutively by the SV40 early promotor. We found that the level of CAT activity obtained with protocol 1 was more than one order of magnitude lower than the level obtained using transfection protocol 2 and that for the most part this reduction in transcriptional activity was observed throughout the deletion series (Fig. 6) . That is, we observed no specific "derepression" of the PLP promotor by the removal of any 5< flanking sequence that was not also apparent in C6 cells maintained at high cell density. The deletion of upstream fragments caused a similar modulation of the base line promotor activity normalized to 100% for the CAT-1038 construct in both transfection protocols. A notable exception was the lack of transcriptional repression observed for sequences upstream of CAT-186, which was only seen in C6 cells cultured at high cell density (Fig. 6) . At high cell density, the strongest CAT activity was observed with clone CAT-186 (16-fold over baseline activity), while at low cell density, CAT-391 gave the strongest signal (threefold over baseline activity).
The PLP regulatory region contains multiple binding sites for C6 nuclear proteins
The regulated expression of the PLP gene in C6 cells suggested to us that these cells might be useful for the identification of trans-acting factors that control the expression of this gene. Inspection of the nucleotide sequence of the rat PLP promotor between positions -1038 and +200 revealed only a few sites with homology to sequences of known protein binding sites (Wingender, 1988) . A putative TATA element (TTTAA) is located 23 bp upstream of the first transcription start site, but no such sequence precedes the remaining start sites at + 16, +43, and + 74 ( Fig. 4 ; with the most 5' transcription start site defined as + 1, the initiation codon occurs at + 164; Milner et al., 1985; Macklin et al., 1987; Ikenaka et al., 1988) . One CCAAT element (5'~CAATTGG-3') resides in an antisense orientation at position -147, and the same 7 bp element is found in the first exon at position + 138.
That regulatory sequences upstream of the PLP promotor are recognized by the same DNA binding proteins present in nuclear extracts prepared from brain and C6 cells was first suggested by gel mobility shift experiments (not shown). Using nuclear extracts prepared from high density C6 glioblastoma cells and PLP-negative NIH3T3 fibroblasts, we then identified individual DNA binding sites using DNase I footprinting procedures. Between position -700 and exon I, we determined the positions and sequences of 14 protein binding sites, 8 of which are illustrated in the representative footprints of Figure 7A . The complete set of sites we identified is schematically summarized in Figure 7B . Strong protection by glial nuclear proteins was observed for the area surrounding the multiple transcription start sites, including sequences encoding the 5' untranslated region of the PLP mRNA. Sequences immediately 5' to the transcription start sites were recognized by proteins in both glial and nor&al nuclear extracts. Further upstream in the PLP gene, several protein binding sites were identified, none of which appeared to be identical with previously described regulatory elements. Two distal footprints (FP330 and FP240) contained sequence repeats within the protected region, which might represent tandem binding sites. For example, the sequence 5'- For each construct, CAT activity has been indicated as the percentage of the value obtained for clone CAT-1038 (= 1 OO%), normalized for the expression of the luciferase gene driven by the SV40 early promotor (at low cell density) and by the PLP promotor (at high cell density). Results are the mean of three separate experiments, and the coefficient of variation (SD x loo/mean) is shown in parentheses.
AYTTCACATG-3' is repeated within FP330. By footprint analysis, the corresponding binding proteins appear much more prominent (per microgram of extract) in C6 cells than in extracts prepared from 3T3 fibroblast nuclei. Similarly, in FP240 the sequence 5'-AATTTCCAC-3' is followed in tandem by the sequence 5'-AATTTACAT-3', which resembles the "octamer" motif (!I'-ATTTGCAT-3', Hatzopoulos et al., 1988) and the binding site of the POU domain transcription factor Pit-l (5'-T/A T/A TATNCAT-3'; Nelson et al., 1988) .
Although the function of the DNA binding proteins responsible for these footprints is presently unknown, a correlation between the position of a binding site and the result of its deletion from the CAT reporter construct can be made. For example, FP330, FP520, FP560, and FP680 are located with c&regulatory regions whose deletion resulted in a loss of PLP promotor activity. FP440 and FP240, on the other hand, are the only DNase-protected sequences in regions that we have tentatively identified as negative regulatory elements.
Homology to the MBP and PO promotors A computer search for homology between nuclear protein binding sites of the PLP promotor and the 5' flanking sequences of other myelin-specific genes revealed two sites in the PLP gene, FP330 and FP12, with extended homology to elements in the MBP promotor (Fig. 8) . FP330 was the only footprinted sequence in the positive regulatory region between -297 and -39 1. For this footprint, the rat PLP gene (FP330) and its equivalent mouse sequence (Ikenaka et al., 1988) are identical in 30 of 32 nucleotides and include a 13 bp motif A (5'-TCA-CATGACTTYA-3'; open box in Fig. 8B ). However, the homology of the footprinted area between the rodent and the human PLP gene (Hudson et al., 1989 ) is low, with only 20 of 32 nucleotides preserved. The human PLP gene instead contains motif B (5'-GGGCTCTCA-3'; shaded box in Fig. 8B ) immediately 5' to motif A. Motif B is also found in the 5' flanking region ofthe rodent MBP gene (Miura et al., 1989) . Surprisingly, motif B has not been preserved in the human MBP gene (Boylan et al., 1990) , and in the equivalent position of this gene motif A is present. Thus, in comparing the rodent and human PLP and MBP genes, the consensus motifs A and B appear to substitute for each other. As shown in Figure 8B , the homology of motif B between the PLP and MBP genes extends to the promotors of the rodent and human P, genes R. Kuhn, personal communication) and the rat MAG gene (D. Montag and R. Milner, personal communication) . Whether the A and B sequences are, in fact, transcriptional regulators of myelin-specific genes, and thus recognized by common transacting factors, awaits further investigation.
Discussion
Myelin gene expression in a glial progenitor cell line
Like the expression of many neuronal genes in the CNS, the transcription of myelin genes in oligodendrocytes is restricted to postmitotic cells. Lacking a suitable in vivo system, the mechanisms regulating myelin genes during CNS development are unknown. We found that rat C6 glioblastoma cells exhibit regulated expression of the PLP gene. Abundant transcription of this gene was only observed under growth arrest conditions of high cell density and serum-free culture, and not during exponential growth. As noted above, it is likely that C6 cells have derived from a glial precursor cell related to or with properties of O-2A cells and have maintained the potential to express glialspecific differentiation markers. Although the plasticity of C6 cells cannot be considered a model system for the differentiation of glial progenitor cells, it should be noted that the changing pattern of gene transcription in C6 cells at high cell density and upon withdrawal of serum parallels in part the oligodendroglial differentiation of O-2A cells cultured in serum-free medium (Raff, 1989) .
Although high levels of mRNA encoding the myelin-associated enzyme CNP were apparent in C6 cells cultured at either low or high cell density, we were unable to detect the endogenous mRNAs for MBP and MAG, two myelin-specific proteins expressed in terminally differentiated oligodendrocytes, under any culture condition. This observation is consistent with the sequential emergence of myelin gene transcripts in the developing rat brain, which have been detected closely spaced in the temporal order (1) CNP, (2) PLP, and (3) MBP (Kanfer et al., 1989) . Alternatively, it is possible that the lack of detectable MBP and MAG mRNAs in C6 cells results from mutations in these genes or from their inactivation by methylation. The presence of a low level of astroglial-specific GFAP mRNA was not unexpected, since a subset of C6 cells in culture has been reported to stain positive with an antibody for GFAP (Bissell et al., 1975; Raju et al., 1980) . However, we noticed only a small change in abundance of GFAP mRNA under those conditions that greatly induced PLP transcription and downregulated vimentin mRNA. Whether the transcription of astroglial and oligodendroglial marker genes is mutually exclusive at the single-cell level awaits a more detailed comparison.
The observation that PLP mRNA abundance in confluent cells is further increased when serum is removed suggests that FCS contains factor(s) that inhibits PLP expression independently ofthe effect ofcell density. Obvious candidates are growth factors such as platelet-derived growth factor (PDGF) and basic FGF (bFGJ?), which inhibit oligodendroglial differentiation of primary glial stem cells in culture (Richardson et al., 1988; BSgler et al., 1990) . A previous attempt to detect high-level expression of PLP mRNA in C6 cells was unsuccessful, possibly because the cells were maintained in the presence of 17.5% serum and medium was changed daily (Macklin et al., 1986) .
Transcriptional control elements of the PLP gene Our primary interest in this study was (1) to analyze the regulation of the PLP gene in a simple cell culture system and (2) to obtain a bona fide source of the DNA binding proteins involved in its transcriptional activation. The PLP gene is also expressed in cultured Schwann cells (Nave et al., 1988) ; however, the level of transcription is at least IO-fold lower than in oligodendrocytes. In gene transfer experiments, the cloned PLP promotor was able to drive both transient and stable expression of the CAT reporter gene in C6 cells. CAT expression was highest under the same conditions (high density/low serum) that induce high levels of PLP mRNA in both C6 cells and oligodendrocytes, suggesting that these cells regulate PLP mRNA by induced transcription and that the induction is largely mediated by c&-acting elements contained within the cloned 5' flanking region of the PLP gene. These data suggest that the regulated expression of CAT-1038 in C6 cells is cell-type specific. This is an important observation, since similar to other cell-type-specific promotors (Sehgal et al., 1988) plasmid CAT-1038 is also "nonspecifically" expressed in some but not all PLP-negative, nonglial cell lines (e.g., 3T3 cells) (K.-A. Nave and G. Lemke, unpublished observations) . In this respect, the specificity of pMBP-CAT expression in C6 cells remains to be determined, since MBP mRNA has not been detected in C6 cells under any culture condition tested. As noted above, it is possible that DNA methylation or mutation have inactivated the C6 MBP gene.
We used footprint analysis with nuclear extracts from C6 cells maintained at high density to identify the positions and sequences of protein binding sites in the PLP promotor. Unfortunately, the small number of cells that can be harvested from a cell monolayer at "low density" did not permit us to compare directly the footprints from nuclear extracts. The PLP core promotor, including the area surrounding the transcription start sites, was well protected from DNase I digestion, and a determination of the exact number of binding sites must therefore await fractionation of the nuclear extracts. While most of the protected sequences are novel when compared to previously described binding sites in other eukaryotic promotors and enhancers (Wingender, 1988) we noticed that corresponding nuclear DNA binding proteins of some sequences are present in a variety of cell types (Nave and Lemke, unpublished observations) . Although transcription factors generally bind sequence specifically, overlapping binding activities and target specificities in vitro have been observed for several genes (Levine and Hoey, 1988) . As a clonal cell line, C6 cells might represent a particularly favorable source of transcription factors for the PLP gene. Using these cells, we hope to avoid problems associated with the artifactual mixture of DNA binding proteins present in whole-brain extracts.
When the 5' regulatory region of the PLP gene was progressively deleted, we found that both positive and negative regulatory elements determined the transcriptional activity of the PLP promotor. Negative cis-regulatory elements ("silencers") have been characterized in other cell-type-specific genes (Winoto and Baltimore, 1989; Baniahmad et al., 1990; Mori et al., 1990) and are thought to regulate gene expression by repression and, in combination with positive regulatory elements, by specific derepression. It is possible that downregulated PLP gene transcription in exponentially growing C6 cells as well as the suppressive effect of serum are mediated by such negative cisregulatory elements. However, when normalized to the activity A in the human PLP gene, is in turn homologous to a sequence at the same position in the rodent MBP gene, and is also found in the myelin genes for rodent and human P, and rat MAG (MOTIF B).
of the "full-length" PLP promotor (clone CAT-1038 in this study), we observed no derepression with any 5' deletion of the regulatory region under low-density culture conditions. In contrast, one negative regulatory element located between -278 and -196 (presumably FP240) showed its repressive effect only in C6 cells at high density and had no effect on promotor strength when analyzed in proliferating cells.
A sequence in FP330, a footprinted element in a distal PLP regulatory region, is related to sequences found in the genes encoding MBP, P,, and MAG (Fig. 8B ). There is evidence from outside the nervous system that functionally related genes contain common cis-regulatory elements. For example, genes encoding the pancreatic enzymes chymotrypsin B, trypsin I, and elastase I share one critical element contained in a DNase I footprint of their 5' flanking sequence (Nelson et al., 1990 and citations therein) , and the myosin heavy-chain gene, creatine kinase gene, and ACh receptor genes of developing muscle cells are each regulated by binding of the truns-regulator myoD (Lassar et al., 1989) . It is therefore possible that coordinate expression of the major myelin genes in the CNS and PNS is transcriptionally controlled, in part, by common truns-regulatory proteins.
